Exosomal NAMPT from Engineered Mesenchymal Stem Cells Mitigates Aortic Stenosis via Metabolic and Anti-Inflammatory Pathways.

Int J Mol Sci · 2025 · PMC12785966 · PMID 41516133

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Notably, NAMPT-Exo administration reduced aortic valve peak velocity and showed a favorable trend in lowering the peak pressure gradient, indicating mitigation of valvular outflow obstruction.

also in 993 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.